Part II: Does Your Patent Office Post-Grant Strategy Account for the Rise of Serial Challenges Flowing From the PTAB to the CRU?

In a March 2025 article, we provided strategy considerations for both parties handling ex parte reexaminations following denied inter partes reviews (IPRs) in view of the United States Patent and Trademark Office (USPTO) Acting Director’s new rules and procedures. Fast forward six months, and the newly-sworn-in Director has proposed additional new rules and procedures as discussed in a client alert earlier this month….
By: Sterne, Kessler, Goldstein & Fox P.L.L.C.